#
Dr. George McDonald

Liver Complications Following Antibody-Drug Conjugate Therapy

The advent of antibody-drug conjugates (ADC), designed to deliver a toxic moiety into tumor cells, has altered the approach to many cancers, particularly hematologic malignancies. However, unexpected toxicity has been seen after ADC therapies.

Read More
#
Dr. Neelendu Dey

Probiotics’ Effects on the Microbiome Vary Widely

Experiments in mice and people find that probiotic supplements don’t consistently change the composition of the gut microbiome, and may have adverse effects after antibiotics.

Read More
#
CMiST Inaugural Symposium

Community & Connectivity in the Microbiome | October 2 & 3

This symposium will bring together accomplished and forward-thinking researchers from a variety of backgrounds who have expertise in their respective fields and offer a unique program that reflects the interdisciplinary nature of the microbiome itself.

Register Online
#
Dr. Richard M. Peek, Jr., MD

Wade Volwiler Visiting Professor Topic: H. pylori | Oct 11 & 12

We are pleased to welcome Dr. Richard Peek, Director of the Division of Gastroenterology at Vanderbilt University, as our 2018 Wade Volwiler Visiting Professor. This 3-part lecture series will focus on the topic of Helicobacter pylori.

Lecture Schedule
#
Dr. George Ioannou

Estimating Risk of HCC Post HCV Antiviral Treatment

Most patients with hepatitis C virus have been treated or will be treated with direct-acting antivirals. It is important that we can model the risk of hepatocellular carcinoma in these patients.

Read More